WASHINGTON, Aug. 2, 2017 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today announced financial and operational results for the second quarter ended June 30, 2017.
“During the second quarter of 2017, we advanced our company growth strategy and delivered strong operational and financial results,” said Mihael H. Polymeropoulos, M.D., Vanda’s President and CEO.
